Company DT&CRO CO., Ltd.

Equities

A383930

KR7383930005

Healthcare Facilities & Services

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Medical & Diagnostic Laboratories

End-of-day quote Korea S.E. Other stock markets 23:00:00 27/05/2024 BST			5-day change	1st Jan Change
8,370 ^KRW	-1.99%		-5.21%	-53.83%

02-22	DT&CRO CO., Ltd. announced that it has received KRW 16 billion in funding from a group of investors	CI
02-20	DT&CRO CO., Ltd. announced that it expects to receive KRW 16 billion in funding from a group of investors	CI

DT&CRO Co Ltd is a Korea-based company principally engaged in the contract research business. The Company is engaged in the provision of non-clinical and clinical trial services in the fields of pharmaceuticals, medical devices, food, chemicals and cosmetics. The Company is also engaged in the provision of analysis, efficacy evaluation and other services.

KRW in Million	2022	Weight	2023	Weight	Delta
Non-clinical 52.1 %	15,147	34.4 %	13,848	52.1 %	-8.58%
Analysis 24.3 %	8,006	18.2 %	6,467	24.3 %	-19.22%
Clinical 13.6 %	18,327	41.6 %	3,617	13.6 %	-80.26%
Efficacy 10.0 %	2,528	5.7 %	2,654	10.0 %	+5.02%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 99.6 %	43,948	99.9 %	26,474	99.6 %	-39.76%
Overseas 0.4 %	60	0.1 %	112	0.4 %	+88.26%

Managers	Title	Age	Since
Chae-Kyu Park CEO	Chief Executive Officer	63	31/12/17
Su-Young Choi PSD	President	67	31/08/21
Hak-Jae Lee BRD	Director/Board Member	54	31/03/17
Deok-Sung Sun BRD	Director/Board Member	55	31/01/18
Jong-Myeong Song AUD	Comptroller/Controller/Auditor	50	28/02/22

Members of the board	Title	Age	Since
Chae-Kyu Park CEO	Chief Executive Officer	63	31/12/17
Deok-Sung Sun BRD	Director/Board Member	55	31/01/18
Hak-Jae Lee BRD	Director/Board Member	54	31/03/17
Sung-Kyu Lee BRD	Director/Board Member	51	31/05/22

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	12,770,512	7,382,287 ( 57.81 %)	0	57.81 %

Name	Equities	%	Valuation
DT&C.CO.,LTD 40.72 %	5,200,000	40.72 %	25 M ₩
Aju IB Investment Co., Ltd. (Private Equity) 4.725 %	603,368	4.725 %	3 M ₩
Chae-Kyu Park 1.378 %	176,000	1.378 %	848 100 ₩
DT&CRO Co., Ltd. ESOA 0.7011 %	89,536	0.7011 %	431 452 ₩
Jong-young Kim 0.1566 %	20,000	0.1566 %	96 375 ₩
Jeong Seong-won 0.0392 %	5,000	0.0392 %	24 094 ₩
Jeong Hyeyeon 0.0188 %	2,400	0.0188 %	11 565 ₩
Hye-yeon Jeong 0.0188 %	2,400	0.0188 %	11 565 ₩
Deok-Sung Sun 0.003923 %	501	0.003923 %	2 414 ₩

DT&CRO Co. Ltd.

28 Baengnyeong-ro 20beon-gil Cheoin-gu

17042, Yongin-si

http://www.dtncro.com

Healthcare

Healthcare Services

Healthcare Providers & Services

Healthcare Facilities & Services

Medical & Diagnostic Laboratories

	1st Jan change	Capi.
DT&CRO CO., LTD.	-53.83%	79.91M
SONIC HEALTHCARE LIMITED	-24.38%	7.83B
RADNET, INC.	+70.87%	4.32B
DR. LAL PATHLABS LIMITED	+1.53%	2.63B
SYNLAB AG	-7.18%	2.53B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-44.62%	2.29B
NEOGENOMICS, INC.	-12.67%	1.82B
FLEURY S.A.	-19.62%	1.51B
METROPOLIS HEALTHCARE LIMITED	+18.85%	1.22B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-43.60%	1.17B

Medical & Diagnostic Laboratories